What's New in the Guidelines? Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States

Tuesday, May 20, 2014 - 3:00pm to 4:00pm EDT

CDC’s Elimination of Mother-to-Child (EMCT) Stakeholders Group, in collaboration with the Franҫois-Xavier Bagnoud (FXB) Center and AETC National Resource Center would like to invite you to participate in this free webinar entitled “What's New in the Guidelines? Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States,” presented by Judy Levison, MD, MPH of the Baylor College of Medicine.


Normal 0 false false false EN-US X-NONE X-NONE MicrosoftInternetExplorer4

Save the Date: The webinar will be held on Tuesday, May 20th, 2014 from 3-4:00 PM ET.

Registration: Pre-registration is REQUIRED for participation. To register please visit: http://aetc.adobeconnect.com/e61oxv1vjca/event/registration.html

Learning Objectives

At the end of this session, participants will be able to discuss and describe guideline updates, including new content on:

  • Preconception Counseling and Care for HIV-Infected Women of Childbearing Age
  • Reproductive Options for HIV-Concordant and Serodiscordant Couples
  • Recommendations for Use of Antiretroviral Drugs during Pregnancy
  • Intrapartum Antiretroviral Therapy/Prophylaxis
  • Postpartum Follow-Up of HIV-Infected Women
  • Infant Antiretroviral Prophylaxis

S M T W T F S
 
 
 
 
 
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31